US Patent Issued to Elgan Pharma on Feb. 17 for "Insulin formulations and methods of using same in preterm infants" (Israeli Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,538, issued on Feb. 17, was assigned to Elgan Pharma Ltd (Nazareth, Israel).

"Insulin formulations and methods of using same in preterm infants" was invented by Michal Olshansky (Tel Aviv, Israel), Elena Ostrovsky (Rishon-LeZion, Israel) and Stav Zeldis (Herzeliya, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "An insulin formulation and a method of preparing and using same. The insulin preparation includes insulin, oligosaccharide and sodium chloride at a ratio of 1:A:B (w:w:w respectively) with ranges of A and B are 1000-5000 and 10-50, respectively."

The patent was filed on Jan. 29, 2024, under Application No. 18/424,936.

*For further in...